Experienced investment executive focused on growth equity and operational improvement across technology and healthcare sectors. Carol Smith brings senior experience in portfolio management, deal sourcing, and strategic finance, having led cross-functional teams and executed bolt-on acquisitions. Known for structuring value-oriented investments, driving EBITDA expansion and supporting board-level governance; frequently engages with LPs, CFOs and founders on capital strategies and exit planning.
Experienced investment executive focused on growth equity and operational improvement across technology and healthcare sectors. Carol Smith brings senior experience in portfolio management, deal sourcing, and strategic finance, having led cross-functional teams and executed bolt-on acquisitions. Known for structuring value-oriented investments, driving EBITDA expansion and supporting board-level governance; frequently engages with LPs, CFOs and founders on capital strategies and exit planning.
Prefers growth-equity investments in technology and healthcare where active operational stewardship can accelerate revenue and EBITDA expansion. Emphasizes structured, value-oriented deals with clear governance and board engagement, often deploying bolt‑on M&A to deepen product or market positions. Focuses on cross‑functional diligence, aligning management incentives and capital structures to optimize exit timing and LP outcomes. Time horizon is medium-to-long term, balancing growth upside with disciplined downside protection through covenants, staged financings and conservative leverage. Competitive edge derives from hands-on portfolio operations, strategic finance expertise and strong founder/CFO relations to execute scaling plans.
Prefers growth-equity investments in technology and healthcare where active operational stewardship can accelerate revenue and EBITDA expansion. Emphasizes structured, value-oriented deals with clear governance and board engagement, often deploying bolt‑on M&A to deepen product or market positions. Focuses on cross‑functional diligence, aligning management incentives and capital structures to optimize exit timing and LP outcomes. Time horizon is medium-to-long term, balancing growth upside with disciplined downside protection through covenants, staged financings and conservative leverage. Competitive edge derives from hands-on portfolio operations, strategic finance expertise and strong founder/CFO relations to execute scaling plans.
| Trades 650 | Longs Won 393/650 60% | Profit Factor 3.46 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.3M |
| Average Win $399,528.59 | Best Trade (Aug 14) $28.29M | Sharpe Ratio -10.57 |
| Average Loss -$176,492.12 | Worst Trade (Mar 31) -$4.38M | Z-Score 9.42 (100%) |
| Commissions $0 | Avg. Trade Length 1y 3m 3w 2d | Expectancy $171,778.86 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% |
| Consecutive Losing Trades | 2,463 | 2,217 | 1,970 | 1,724 | 1,478 | 1,232 | 985 | 739 | 493 | 246 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 865 | $170,431.42 | $267,207.15 | - | $96,775.73 | 56.78% | -7.354% |
ABBV AbbVie Inc. | 238 | $44,178 | $59,723.72 | - | $15,545.72 | 35.19% | -2.513% |
ABT Abbott Laboratories | 320 | $43,524 | $33,824 | - | -$9,700 | -22.29% | +0.085% |
ACFN Acorn Energy Inc. | 1,200 | $30,608 | $22,620 | - | -$7,988 | -26.1% | -4.12% |
ACRE Ares Commercial Real Estate Corporation | 112,700 | $974,787.37 | $480,102 | - | -$494,685.37 | -50.75% | -1.16% |
ADI Analog Devices, Inc. | 189 | $44,986 | $69,440.49 | - | $24,454.49 | 54.36% | +0.202% |
ADSK Autodesk, Inc. | 90 | $27,862 | $21,078 | - | -$6,784 | -24.35% | -0.328% |
AEM Agnico Eagle Mines Limited | 40,000 | $2.19M | $5.81M | - | $3.62M | 164.85% | -3.635% |
AMZN Amazon.com Inc | 213 | $46,730.18 | $57,846.54 | - | $11,116.36 | 23.79% | +15.321% |
AON Aon plc | 62 | $22,120 | $22,354.1 | - | $234.1 | 1.06% | -1.642% |
APO Apollo Global Management, Inc. | 141,409 | $13.21M | $17.76M | - | $4.55M | 34.47% | +4.441% |
ARCC Ares Capital Corporation | 30,675 | $614,420.65 | $575,463 | - | -$38,957.65 | -6.34% | -0.372% |
ARE Alexandria Real Estate Equities, Inc. | 10,200 | $740,826.41 | $524,790 | - | -$216,036.41 | -29.16% | -1.981% |
AVT Avnet Inc. | 80,000 | $4.03M | $7.11M | - | $3.08M | 76.27% | +2.35% |
AVUV Avantis U.S. Small Cap Value ETF | 2,595 | $286,670 | $325,101.6 | - | $38,431.6 | 13.41% | +0.032% |
AXP American Express Company | 82 | $26,157 | $27,572.5 | - | $1,415.5 | 5.41% | -0.376% |
BAC Bank of America Corporation | 210,075 | $7.07M | $13.01M | - | $5.94M | 83.97% | +0.356% |
BALL Ball Corp. | 58,470 | $3.46M | $3.79M | - | $338,541 | 9.8% | -0.628% |
BLK BlackRock, Inc. | 12 | $12,591 | $13,084.68 | - | $493.68 | 3.92% | -0.727% |
BNY BlackRock New York Municipal Income Trust | 150 | $13,667 | $23,449.5 | - | $9,782.5 | 71.58% | +0.16% |